Ex parte ARRAUDEAU et al. - Page 5




          Appeal No. 95-3562                                                          
          Application No. 08/110,996                                                  


          examiner’s assertions, the examiner has cited Remington’s                   
          Pharmaceutical Sciences which indicates that propylene glycol               
          is used as a solvent, preservative and a humectant.                         
               The review of any prior art rejection, whether for                     
          anticipation or obviousness, requires first that the claims                 
          have been correctly construed to define the scope and meaning               
          the relevant limitations.  Gechter v. Davidson, 116 F.3d 1454,              
          1457 43 USPQ2d 1030, 1032 (Fed. Cir. 1997).  As argued by                   
          counsel for appellants at the oral hearing, the claims on                   
          appeal herein expressly and literally exclude the presence of               
          an emulsifying agent by virtue of the claimed language “said                
          composition not containing an emulsifying agent.” See the last              
          line of appealed claim 16.  Thus, whether or not the propylene              
          glycol added in the prior art composition functions as an                   
          emulsifying agent, this compound is excluded by the claim                   
          language “not containing an emulsifying agent.”  Accordingly,               
          we cannot sustain the stated rejection of the appealed claims               
          for obviousness.                                                            
               We further note that the examiner has made no argument                 
          that it would have been obvious to a person of ordinary skill               
          in this art to have omitted the propylene glycol component                  
                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  Next 

Last modified: November 3, 2007